This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
See you next year! September 15 -18, 2025
Hynes Convention CenterBoston, USA
Menu

Thomas Kelly
Director, Cell Engineering & Analytical Sciences at Johnson & Johnson Innovative Medicine
Speaker

Profile

Tom is the Director of the Cell Engineering & Analytical Sciences group for Janssen R&D, leading a team that develops the manufacturing cell lines for all secreted biologics at Janssen. He’s been a member of this team for over 20 years and has contributed to the successful approval of mAbs such as Simponi, Stelara, Tremfya, Sylvant, and Darzalex, as well as bispecific mAbs Rybrevant and Tecvayli. Prior to joining Janssen, Tom worked at the Wistar Institute in Philadelphia. He earned his degree in Chemical & Biomolecular Engineering from the University of Pennsylvania.

Agenda Sessions

  • When Will We Have a Clone? An Industry Perspective on the Typical CLD Timeline

    , 11:45am
    View Session

  • Panel Discussion: Thoughts on Accelerating CLD and FIH studies

    , 5:00pm
    View Session

At this event

Prev
Next
Amol Ketkar
CMTO (Chief Manufacturing and Technical Officer)
Resolution Therapeutics

See Thomas at BioProcess International